3Yared JP,Starr NJ,Torres FK,et al.Effects of singte dose,postinduction dexamethasone on recovery after cardiac surgery[J].The Annals of Thoracic Surgery,2000,69 (5):1420-1424.
4Demellis J,panaretou M.Relationship between C-reac-tive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation[J].Eur Hcart J,2004,25:1100-1107.
5Demellis J,Panaretou M.Efect of C-reactive protein reduction on paroxysmal atrial fib-rillation[J].Am Heart,2005,150:1064e7-1064e12.
6Chung WS,Chu PL,Hung FT.Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardio version[J].Am J Cardiol,2003,92 (11):1343-1345.
7Koichiro K,Hideko N,Keijim S.The HMG-CoA reductase inhibitor atorvastat in prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model[J].Cardiovasc Res,2004,6(1):105-111.
8Frustaci A,Chimenti C,Bellocci F,et al.Histological substrate of atrial biopsies in patients with lone atrial fibrillation[J].Circulation,1997,96:1180-1184.
9Rossi L.Histopathological correlates of atrial flutter[M].Waldo AL,Touboulm P.Atrial Flutter Advances in Mecvhanisms and Man-agement[M].NY:Futura publish,1996:21-28.
10Former M,Genton C,Schlapper J,et al.Is there an isolated arrhyyhmngenic right atrial my ocarditis?[J].Eur Heart J,1990,11 (6):566-571.
二级参考文献13
1Lip GY, Patel JV, Hughes E, et al, High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke, 2007,38: 1229- 1237.
2Dernellis J ,Panaretou M. Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation. Am J Cardiol, 2006, 97: 245- 248.
3Turhan H, Aksoy Y, Yetkin E, et al. The impact of inflammation on the development, successful cardioversion, recurrence and/or perpetuation of atrial fibrillation. Int J Cardiol, 2007, 118: 256-257.
4Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation,2004,109:2-10.
5Aviles RJ, Martin DO, Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation, 2003,108: 3006-3010.
6Chung MK,Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation, 2001,104: 2886-2891.
7Kotsakou E, Tziakas D, Hotidis A, et al. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation. Am J Cardiol, 2006,97 : 659-661.
8Conway DS, Buggins P, Hughes E, et al. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol, 2004,43: 2075- 2082.
9Watanabe T, Takeishi Y, Hirono O,et al. C-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation. Heart Vessels, 2005,20.45-49.
10Malouf JF,Kanagala R, AL Atawi FO, et al. High sensitivity C-reactive protein:a novel predictor for recurrence of atrial fibrillation after successful cardioversion. J Am Coll Cardiol, 2006,46 : 1284-1287.
